12 February 2025 in medRxiv
Spatial transcriptomics technology remains resource-intensive and unlikely to be routinely adopted for patient care soon. This hinders the development of novel precision medicine solutions and, more importantly, limits the translation of research findings to patient treatment. Here, we present DeepSpot, a deep-set neural network that leverages recent foundation models in pathology and spatial multi-level tissue context to effectively predict spatial transcriptomics from standard H&E images. DeepSpot substantially improved gene correlations across multiple datasets from patients with metastatic melanoma, kidney, lung, or colon cancers as compared to previous state-of-the-art. Using DeepSpot, we generated 3,780 TCGA virtual spatial transcriptomics samples (56 million spots) of the melanoma, renal cell cancer, lung adenocarcinoma and lung squamous cell carcinoma cohorts. We anticipate this to be a valuable resource for biological discovery and a benchmark for evaluating spatial transcriptomics models. We hope that DeepSpot and this dataset will stimulate further advancements in virtual spatial transcriptomics analysis.
21 May 2026 in Bioinformatics
Motivation: Spatial transcriptomics enables in-depth molecular characterization of samples on a morphology and RNA level while preserving spatial location. Integrating the resulting multi-modal data is an unsolved problem, and developing new solutions in precision medicine depends on improved methodologies. Results: We introduce AESTETIK, a convolutional deep learning model that jointly integrates spatial, transcriptomics, and morphology information to learn accurate spot representations. AESTETIK yielded substantially improved cluster assignments on widely adopted technology platforms (e.g. 10x Genomics™, NanoString™) across multiple datasets. We achieved performance enhancement on structured tissues (e.g. brain) with a 21% increase in median ARI over previous state-of-the-art methods. Notably, AESTETIK also demonstrated superior performance on cancer tissues with heterogeneous cell populations, showing a two-fold increase in breast cancer, 79% in melanoma, and 21% in liver cancer. We expect that these advances will enable a multi-modal understanding of key biological processes. Availability and Implementation: AESTETIK is implemented in Python 3 and is available as open source software at http://www.github.com/ratschlab/aestetik. The Snakemake pipeline for reproducing the results is available at http://www.github.com/ratschlab/st-rep. Contact: kalin.nonchev@inf.ethz.ch, viktor.koelzer@usb.ch, gunnar.raetsch@inf.ethz.ch Supplementary information: Supplementary data are available at Bioinformatics online.
25 September 2025 in bioRxiv
Spot-based spatial transcriptomics (ST) technologies like 10x Visium quantify genome-wide gene expression and preserve spatial tissue organization. However, their coarse spot-level resolution aggregates signals from multiple cells, preventing accurate single-cell analysis and detailed cellular characterization. Here, we present DeepSpot2Cell, a novel DeepSet neural network that leverages pretrained pathology foundation models and spatial multi-level context to effectively predict virtual single-cell gene expression from histopathological images using spot-level supervision. DeepSpot2Cell substantially improves gene expression correlations on a newly curated benchmark we specifically designed for single-cell ST deconvolution and prediction from H&E images. The benchmark includes 20 lung, 7 breast, and 2 pancreatic cancer samples, across which DeepSpot2Cell outperformed previous super-resolution methods, achieving respective improvements of 46%, 65%, and 38% in cell expression correlation for the top 100 genes. We hope that DeepSpot2Cell and this benchmark will stimulate further advancements in virtual single-cell ST, enabling more precise delineation of cell-type-specific expression patterns and facilitating enhanced downstream analyses. Code availability: https://github.com/ratschlab/DeepSpot